Page 1 Date 13 May 2020 Re: Management Discussion & Analysis for the 3-months period Ended 31 March 2020 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN PUBLIC COMPANY
Page 1 Date 11 November 2020 Re: Management Discussion & Analysis for the 9-months period Ended 30 September 2020 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN PUBLIC
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
Page 1 No. CMC Sor Lor.013/2019 Date 12 November 2019 Re: Management Discussion & Analysis for the Period Ended 30 September 2019 To The President of the Stock Exchange of Thailand (SET
May 13, 2019 SET-19-AC-002 Dear The President The Stock Exchange of Thailand Subject: Clarification of Result’s Operation for the three months ended March 31, 2019 According to the resolution of
13 November 2019 Subject: A Disposition of Assets of a Subsidiary Attn: Director and Manager The Stock Exchange of Thailand We, Land and Houses Public Company Limited would like to inform that On 24
Page 1 of 2 No. ACC1903/001 March 1, 2019 Subject: Approval to enter into Contract to sell of Common Stock To: President The Stock Exchange of Thailand According to the Board of Director’s Meeting No
fee (total expense ratio) of equity large cap funds was around 1.76% charged by AMCs in Thailand. Fee (p.a.) Total fee Sharing on Return 0.50% 35,760 12% 1.50% 98,083 34% 2.00% 125,154 44% 3.00% 172,238
Page 1 No. CMC Sor Lor.009/2019 May 14, 2019 Re: Management Discussion & Analysis for the Period Ended 31 March 2019 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN
วันที่ 25 กุมภาพันธ์ 2558 August 10, 2018 Subject: Management’s Discussion and Analysis for the 6 months period ended June 30, 2018 Attention: Director and Manager The Stock Exchange of Thailand LDC